Abstract: Disclosed is a technology of discharging, from a drug cartridge, a drug instructed to discharge, while managing a plurality of drugs stored in a drug cartridge. The technology makes it possible to correctly discharge the drugs even when the dosing order of the drugs is changed. A medical agent dispenser has: a main body case (1); an annular drug cartridge (2) which is housed in the main body case (1) and has a plurality of holders (3) at equal intervals in the longitudinal direction; a discharge mechanism (7) which discharges the drugs from the holders (3); and an input interface (6) which receives operations of leading the drug to be discharged. Based on the number of operations the input interface (6) has received, gears (4a, 4b), i.e., rotating mechanisms which rotationally transfer the drug cartridge (2), are controlled.

Abstract: An object of the present invention is to provide a monoclonal antibody which is useful as a diagnostic agent or a therapeutic agent for a disease relating to a polypeptide encoded by Claudin-4 (hereinafter referred to as “CLDN4”) gene or a polypeptide encoded by a Claudin-3 (hereinafter referred to as “CLDN3”) gene, or a method for using the same.

Abstract: A drive voltage supply circuit has a first wire line, a second wire line, a first drive circuit, a plurality of second drive circuits, a control circuit for driving the first drive circuit and the plurality of second drive circuits, and an impedance element connected between the first wire line and each of output terminals.

Abstract: The present invention includes a novel shapeable material or resin, specifically for dental use. It is an improvement over conventional dental resins because it is strong, safe, does not encourage the propagation of bacteria and contains no bisphenol A (BPA). Also, it is the preferred resiliency for use in the oral cavity.

Abstract: On a semiconductor chip in a semiconductor integrated circuit, a plurality of circuit cells each of which has a pad are formed along a first chip side of the semiconductor chip. Among the plurality of circuit cells, one or more circuit cells at least in the vicinity of an end portion on the first chip side are arranged having a steplike shift in a direction apart from the first chip side with decreasing distance from the center portion to the end portion on the first chip side.

Abstract: Disclosed are a curable composition characterized by using a curable composition including an organic polymer (A1) having one or more silicon-containing functional groups capable of cross-linking by forming siloxane bonds in which the one or more silicon-containing functional groups capable of cross-linking by forming siloxane bonds are silicon-containing functional groups each having three or more hydrolyzable groups on one or more silicon atoms thereof; and a method for controlling the recovery properties, durability and creep resistance of the cured article. Herewith, the present invention provides a curable composition capable of giving a cured article excellent in recovery properties, durability and creep resistance, and a method for controlling the recovery properties, durability and creep resistance of the cured article.

Abstract: The collector, emitter, and base of a bipolar transistor circuit are connected to a high side power supply terminal, the drain of a level shift transistor, and a floating power supply terminal, respectively. When a high side output transistor is on, the floating power supply terminal is at the potential of a high potential power supply terminal. The high side power supply terminal is at a potential higher than the potential of the floating power supply terminal by a constant voltage. Turning the level shift transistor on, its drain potential drops below the potential of the floating power supply terminal; The base current flows through the bipolar transistor circuit and the drain potential of the level shift transistor is clamped near the potential of the floating power supply terminal; The bipolar transistor circuit is turned on and its collector current supplies the drain current of the level shift transistor.

Abstract: Disclosed are a curable composition characterized by using a curable composition including an organic polymer (A1) having one or more silicon-containing functional groups capable of cross-linking by forming siloxane bonds in which the one or more silicon-containing functional groups capable of cross-linking by forming siloxane bonds are silicon-containing functional groups each having three or more hydrolyzable groups on one or more silicon atoms thereof; and a method for controlling the recovery properties, durability and creep resistance of the cured article. Herewith, the present invention provides a curable composition capable of giving a cured article excellent in recovery properties, durability and creep resistance, and a method for controlling the recovery properties, durability and creep resistance of the cured article.

Abstract: Medicaments for treating diseases related to HB-EGF escalation are in demand. The present invention provides a monoclonal antibody or an antibody fragment thereof which binds to a cell membrane-bound HB-EGF, a membrane type HB-EGF and a secretory HB-EGF.

Abstract: Medicaments for treating diseases related to HB-EGF escalation are in demand. The present invention provides a monoclonal antibody or an antibody fragment thereof which binds to a cell membrane-bound HB-EGF, a membrane type HB-EGF and a secretory HB-EGF.

Abstract: A helmet that can be removed from the head of a helmet wearer who wears the helmet, with a comparatively small force, and simply and quickly including preliminary operation for removal. A recess-projection fitting mechanism to attach a blockish inside pad to a head protecting cap portion includes a male hook on a blockish inside pad side, and a female hook on a head protecting cap portion side. The interrupt portion of a pad takeout member including a pulling means can interrupt between the male hook and female hook to disengage their recess-projection fitting, and can catch on the male hook, and the male hook can be pulled out to outside the head protecting cap portion at least halfway.

Abstract: In a semiconductor integrated circuit device of the present invention, temperature increase of a bonding wire can be suppressed even when conductive leads are short-circuited with each other, and reliability of the semiconductor integrated circuit device is improved. The conductive leads of a resin package for supplying a power supply section of a semiconductor integrated circuit chip with power from an external power supply are connected with bonding pads of the semiconductor integrated circuit chip by a plurality of bonding wires. Furthermore, the conductive leads connected to a GND for supplying the power supply section of the semiconductor integrated circuit chip with a grounding potential are connected with the bonding pads of the semiconductor integrated circuit chip by a plurality of bonding wires.

Abstract: Medicaments for treating diseases related to HB-EGF escalation are in demand. The present invention provides a monoclonal antibody or an antibody fragment thereof which binds to a cell membrane-bound HB-EGF, a membrane type HB-EGF and a secretory HB-EGF.

Abstract: An object of the present invention is to provide a monoclonal antibody which is useful for treating or diagnosing a disease relating to system ASC amino acid transporter 2 (hereinafter, referred to as “ASCT2”) or a method using the antibody. The present invention provides a monoclonal antibody which specifically recognizes a native three-dimensional structure of an extracellular region of ASCT2 and binds to the extracellular region, or an antibody fragment thereof; a hybridoma which produces the antibody; a DNA which encodes the antibody; a vector which contains the DNA; a transformant obtainable by introducing the vector; a process for producing an antibody or an antibody fragment thereof using the hybridoma or the transformant; and a therapeutic agent using the antibody or the antibody fragment thereof, and a diagnostic agent using the antibody or the antibody fragment thereof.

Abstract: Medicaments for treating diseases related to HB-EGF escalation are in demand. The present invention provides a monoclonal antibody or an antibody fragment thereof which binds to a cell membrane-bound HB-EGF, a membrane type HB-EGF and a secretory HB-EGF.

Abstract: To provide a game system in which each of the players in turn controls a common character (operation object) so as to enjoy a continuous electric game; and to provide a game system in which a previous player who has been replaced by another player still has willing to participate in the game. There is provided a game system to which a plurality of players can access via respective operation terminals.

Abstract: A wireless blood glucose meter (2) has a blood glucose level detector (21), a transmitter (22), a receiver (23), a storage component (24), and a transmission power determiner (25). Whether or not an acknowledge signal has been received and the transmission power when the transmitter (22) has transmitted a blood glucose level are stored as history information in the storage component (24), and the transmission power determiner (25) determines the transmission power when the transmitter (22) transmits on the basis of the history information stored in the storage component (24).

Abstract: A display driver includes a shift register; an OR circuit configured to perform an OR operation on data signals respectively representing bits in the shift register which are not adjacent to each other, and to output a result of the OR operation; a delay circuit configured to delay the output of the OR circuit, and to output the delayed output; timing generators respectively corresponding to the data signals, where each of the timing generators generates and outputs a first control signal including a first pulse and a second control signal including a second pulse in accordance with a corresponding one of the data signals and the output of the delay circuit; and output circuits respectively corresponding to the timing generators, where each of the output circuits outputs voltages of a first and a second power supply. A duration of the second pulse includes a duration of the first pulse.

Abstract: A semiconductor integrated circuit includes a plurality of circuit cells each including a pad on a semiconductor chip. Each of the circuit cells includes a high-side transistor, a level shift circuit, a low-side transistor, a pre-driver, and a pad. The high-side transistor and the low-side transistor are arranged to face each other with the pad interposed therebetween.

Abstract: On a semiconductor chip in a semiconductor integrated circuit, a plurality of circuit cells each of which has a pad are formed along a first chip side of the semiconductor chip. Among the plurality of circuit cells, one or more circuit cells at least in the vicinity of an end portion on the first chip side are arranged having a steplike shift in a direction apart from the first chip side with decreasing distance from the center portion to the end portion on the first chip side.